Description: Myasthenia Gravis, Part A, Volume 182 in the International Review of Neurobiology series, highlights new advances in the field, with this new volume presenting interesting chapters on topics such as the Structure of the NMJ and Neuromuscular Transmission, Neuromuscular Junction and the Complement System, Regulation of the Autoimmune Response, The Thymus, Antibodies/Subclasses (IgG) and Antigens, Cell Models of MG, Mouse Models of EAMG and Passive Immunization, Epidemiology of Myasthenia Gravis, Special Populations: Juvenile, Early, Late, and Very Late-Onset, Blood and Digital Biomarkers in MG, Lambert-Eaton Myasthenic Syndrome, and Congenital Myasthenic Syndromes.
Brief description:
Dr. Barnett-Tapia's main research interest is patient-centered outcomes and patient preference elicitation in patients with Neuromuscular Disorders and Neurofibromatosis. She developed the Myasthenia Gravis Impairment Index (MGII) a novel, patient-centred measure of disease severity. She has received funding from MGNet and Muscular Dystrophy Canada to study how people with myasthenia gravis make treatment decisions. She is a member of the scientific council of the Myasthenia Gravis of America (MGFA). In 2020, she was the inaugural recipient of the Surinderjit Singh Young Lectureship Award, from the American Academy of Neuromuscular and Electrodiagnostic Medicine (AANEM) and in 2023 she received the MGFA medical partner of the year award.